INTRODUCTION: We retrospectively investigated and summarized our experiences and the outcomes of organ-sparing surgery (OSS) for testicular tumour with benign tendency. METHODS: From April 2000 to March 2012, 11 selected patients with testicular tumour underwent OSS. Preoperative and postoperative organ functional and oncologic indexes were analyzed and compared. RESULTS: All operations were completed without conversion to radical orchiectomy. Intraoperative frozen section and routine postoperative pathology showed tumours with benign tendency. The normal appearance of the scrotum and functional integrity of the testis were preserved. Preoperative and postoperative serum sex hormone levels, international index of erectile function (IIEF-5) scores, and semen quality were not significantly different. Tumour recurrence or metastasis did not occur during follow-up. CONCLUSIONS: Our results showed the feasibility and safety of OSS to treat testicular tumour with benign tendency. With careful selection and rigorous follow-up, some testis tumor can be treated with OSS to maximally maintain normal appearance and function of the testis. The retrospective single-centre study and small sample size are main limitations. More evidence is needed to establish the large-scale application of OSS.
INTRODUCTION: We retrospectively investigated and summarized our experiences and the outcomes of organ-sparing surgery (OSS) for testicular tumour with benign tendency. METHODS: From April 2000 to March 2012, 11 selected patients with testicular tumour underwent OSS. Preoperative and postoperative organ functional and oncologic indexes were analyzed and compared. RESULTS: All operations were completed without conversion to radical orchiectomy. Intraoperative frozen section and routine postoperative pathology showed tumours with benign tendency. The normal appearance of the scrotum and functional integrity of the testis were preserved. Preoperative and postoperative serum sex hormone levels, international index of erectile function (IIEF-5) scores, and semen quality were not significantly different. Tumour recurrence or metastasis did not occur during follow-up. CONCLUSIONS: Our results showed the feasibility and safety of OSS to treat testicular tumour with benign tendency. With careful selection and rigorous follow-up, some testis tumor can be treated with OSS to maximally maintain normal appearance and function of the testis. The retrospective single-centre study and small sample size are main limitations. More evidence is needed to establish the large-scale application of OSS.
Authors: Nicolai Leonhartsberger; Christian Gozzi; Thomas Akkad; Brigitte Springer-Stoehr; Georg Bartsch; Hannes Steiner Journal: BJU Int Date: 2007-04-13 Impact factor: 5.588
Authors: Aseem R Shukla; Christopher Woodard; Michael C Carr; Dale S Huff; Douglas A Canning; Stephen A Zderic; Thomas F Kolon; Howard M Snyder Journal: J Urol Date: 2004-01 Impact factor: 7.450
Authors: Miroslav Louda; Martin Valis; Jaroslava Splichalova; Jaroslav Pacovsky; Baker Khaled; Miroslav Podhola; Jan Jansa; Lucie Hasenohrlova; Pavel Kunc; Milos Brodak Journal: Neuro Endocrinol Lett Date: 2012 Impact factor: 0.765
Authors: Jesse Ory; Udi Blankstein; Daniel C Gonzalez; Aditya A Sathe; Joshua T White; Carlos Delgado; John Reynolds; Keith Jarvi; Ranjith Ramasamy Journal: BJUI Compass Date: 2021-02-23